Company intelligence / Profile preview

Altos Labs

San Francisco Bay Area, California, United States

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Altos Labs is conducting foundational research in cellular reprogramming, aiming to restore cellular health and resilience to reverse or prevent age-related diseases. There are no publicly disclosed clinical results; activities are largely pre-clinical with heavy basic science investment

Therapeutic areas: NeurologyOther
Modalities: Induced pluripotent stem cell derived therapyCell therapyRegenerative medicine
Industry: Biotech

Partnerships

Collaborations with academic scientists and research institutions

Beyond the preview

Go deeper on Altos Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altos Labs.

Explore the full profile